Evidence map›Paper›PMID 39742481›Full record

ArticleScience advances2025

Deep learning predicts DNA methylation regulatory variants in specific brain cell types and enhances fine mapping for brain disorders.

Jiyun Zhou, Daniel R Weinberger, Shizhong Han

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Deep learning for psychiatric genomics: from tools to applications.Current opinion in genetics & development · 2026
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Jiyun ZhouLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21287, USA.ORCID 0000-0002-2145-2976
Daniel R WeinbergerLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21287, USA.ORCID 0000-0003-2409-2969
Shizhong HanLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD 21287, USA.ORCID 0000-0002-5114-6742

Funding

Functional methylomics approaches for schizophrenia in the frontal cortex and hippocampusR01MH112751 · NIMH · LIEBER INSTITUTE, INC. · PI HAN, SHIZHONG · 2017 to 2021
$3.4M
Integrative approaches to identification and interpretation of genes underlying psychiatric disordersR01MH121394 · NIMH · LIEBER INSTITUTE, INC. · PI HAN, SHIZHONG · 2020 to 2023
$2.4M
NIMH NIH HHS R01 MH112751NIMH NIH HHS R01 MH121394
6 · The paper itself

Abstract

DNA methylation (DNAm) is essential for brain development and function and potentially mediates the effects of genetic risk variants underlying brain disorders. We present INTERACT, a transformer-based deep learning model to predict regulatory variants affecting DNAm levels in specific brain cell types, leveraging existing single-nucleus DNAm data from the human brain. We show that INTERACT accurately predicts cell type-specific DNAm profiles, achieving an average area under the receiver operating characteristic curve of 0.99 across cell types. Furthermore, INTERACT predicts cell type-specific DNAm regulatory variants, which reflect cellular context and enrich the heritability of brain-related traits in relevant cell types. We demonstrate that incorporating predicted variant effects and DNAm levels of CpG sites enhances the fine mapping for three brain disorders-schizophrenia, depression, and Alzheimer's disease-and facilitates mapping causal genes to particular cell types. Our study highlights the power of deep learning in identifying cell type-specific regulatory variants, which will enhance our understanding of the genetics of complex traits.

Indexed as

BrainDeep LearningDNA MethylationAdultAlzheimer DiseaseCpG IslandsGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansInheritance PatternsMaleModels, BiologicalNucleotide MotifsTranscription FactorsYoung AdultTranscription Factors

Identifiers

PMID39742481
PMCPMC11691643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.